Announcements Trials
Browse Landscape

Phase

Phase 2 85Phase 3 29Phase 1 20Phase 1/2 11Phase NA 3Phase 2/3 2Phase 4 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 3Upper Gastrointestinal Tumours 1Solid Tumor 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Neutropenia 1Colonic Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Capecitabine 3Radiotherapy 2Oxaliplatin 2Fentanyl 2Bupivacaine 2udenafil 1sodium phosphate 1oxycodone-acetaminophen 1XELOX 1Tramadol 1Sildenafil Citrate 1Sevoflurane 1Propofol 1Pico-Salax 1Orphenadrine 1Neuroleptanalgesia 1Morphine 1Methadone 1Lidocaine 1Leucovorin 1Ketorolac Tromethamine 1Ketorolac 1Ketamine 1Irinotecan 1Hydromorphone 1Hydrocodone 1Gabapentin 1Fluorouracil 1Ertapenem 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Rectal Neoplasms × Irinotecan × Clear all
NCT00559676 2011-05-16

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 4 Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡